Latest stories on ENSC
Ensysce Biosciences registers to sell 433.91M shares of common stock for holders
The Fly22 · bearishgeneral
Ensysce Biosciences participates in Family Office Summit, Dubai
The Fly53 · neutralproduct/pr
Ensysce Biosciences Expands Global Investor and Strategic Outreach at Family Office Summit, Dubai
StockTitan56 · neutralproduct/pr
Ensysce Biosciences initiated with an Overweight at Cantor Fitzgerald
The Fly63 · neutralanalyst
8-K/A - Ensysce Biosciences, Inc. (ENSC) files 8-K
SEC 8-K50 · neutralgeneral
Ensysce Biosciences, Inc. (ENSC) files 8-K
SEC 8-K50 · neutralgeneral
Ensysce Biosciences Phase 2 Protocol for CY200 - A Neuroplastigen for the Treatment of CRPS - Submitted to the UK MHRA
StockTitan63 · neutralproduct/pr
Ensysce Biosciences advances CRPS program at Painweek 2026
The Fly63 · neutralproduct/pr
Ensysce Biosciences Advances CRPS Program at Painweek 2026, Contributes to FDA Hearing on Psychedelic Drug Regulation
StockTitan63 · neutralproduct/pr
Ensysce professor to speak at FDA public hearing on psychedelic drugs
The Fly55 · neutralgeneral
Ensysce Biosciences Announces Upcoming Conference and Industry Event Participation
StockTitan56 · neutralproduct/pr
Ensysce completes enrollment for final phase of PF614-MPAR-102 study
The Fly59 · neutralproduct/pr
Ensysce Biosciences Completes Final Phase of PF614-MPAR-102 Clinical Study
StockTitan63 · neutralproduct/pr
Ensysce Biosciences Gains Nasdaq Equity Compliance, Faces New Listing Hurdles
TipRanks38 · neutralgeneral
Ensysce Biosciences, Inc. (ENSC) files 8-K
SEC 8-K50 · neutralgeneral
Ensysce Biosciences Seeks Extended Nasdaq Compliance Grace Period
TipRanks42 · neutralgeneral
Ensysce Biosciences, Inc. (ENSC) files 8-K
SEC 8-K50 · neutralgeneral
Ensysce Biosciences GAAP EPS of -$0.20 beats by $0.30
Seeking Alpha62 · neutralearnings
Ensysce Biosciences, Inc. (ENSC) files 8-K
SEC 8-K50 · neutralgeneral
Ensysce Biosciences Reports Second Quarter 2026 Financial Results and Recent Business Highlights
StockTitan56 · neutralearnings
8-K/A - Ensysce Biosciences, Inc. (ENSC) files 8-K
SEC 8-K50 · neutralgeneral
Ensysce Biosciences Completes Cy Biopharma Acquisition and Secures Up to $77 Million Private Financing
InvestorsHub63 · neutralm&a
Ensysce Biosciences Completes Cy Biopharma Acquisition and Secures Up to $77 Million Private Financing
Yahoo Finance63 · neutralm&a